Glaukos (GKOS) director Denice Torres granted RSUs and stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
GLAUKOS Corp director Denice Torres reported equity awards as part of standard board compensation. She received 1,878 restricted stock units that will vest in full on the one-year anniversary of the grant date and convert into the same number of common shares. She was also granted stock options for 2,987 shares of common stock with an exercise price of $53.57 per share, vesting in full after one year and expiring in 2036. Following these grants, she directly holds 24,212 shares of common stock, which include 4,609 restricted stock units that have not yet vested or been delivered.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Torres Denice
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 2,987 | $0.00 | -- |
| Grant/Award | Common Stock | 1,878 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 2,987 shares (Direct, null);
Common Stock — 24,212 shares (Direct, null)
Footnotes (1)
- Represents a grant of restricted stock units received by the Reporting Person pursuant to the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. Includes 4,609 restricted stock units that have not yet vested or been delivered to the Reporting Person. Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date
Key Figures
Restricted stock units granted: 1,878 units
Stock options granted: 2,987 options
Option exercise price: $53.57 per share
+3 more
6 metrics
Restricted stock units granted
1,878 units
Director grant vesting after one year
Stock options granted
2,987 options
Director grant on May 28, 2026
Option exercise price
$53.57 per share
Stock Option (Right to Buy)
Common shares after transaction
24,212 shares
Direct holdings following grants
Unvested RSUs included in holdings
4,609 units
Restricted stock units not yet vested or delivered
Option expiration date
May 28, 2036
Stock option term end
Key Terms
restricted stock units, Director Compensation Policy, Stock Option (Right to Buy), exercise price
4 terms
restricted stock units financial
"Represents a grant of restricted stock units received by the Reporting Person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Director Compensation Policy financial
"received by the Reporting Person pursuant to the Issuer's Director Compensation Policy"
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price": "53.5700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What did Glaukos (GKOS) director Denice Torres report in this Form 4?
Denice Torres reported receiving equity compensation awards from Glaukos. She was granted 1,878 restricted stock units and stock options for 2,987 shares, both vesting in full one year after the grant date under the company’s Director Compensation Policy.
How many restricted stock units did Denice Torres receive from Glaukos (GKOS)?
She received 1,878 restricted stock units as a grant under Glaukos’ Director Compensation Policy. These units will vest in full on the one-year anniversary of the grant date and will be settled in an equivalent number of Glaukos common shares.
What are the terms of the stock options granted to Denice Torres at Glaukos (GKOS)?
Torres was granted stock options covering 2,987 shares of Glaukos common stock at an exercise price of $53.57 per share. The options vest in full one year after the grant date and expire on May 28, 2036, if not exercised earlier.
Are the new Glaukos (GKOS) awards to Denice Torres cash transactions?
No, the awards are non-cash equity compensation. The 1,878 restricted stock units convert into shares upon vesting, and the 2,987 stock options allow share purchases at $53.57 per share after vesting, rather than involving immediate cash payments to acquire the awards.